Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.79 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL344339 | 0.90 | ALDH1A1 (0.79) | ALDH1A1TSHRTHRBTDP1KEAP1 | |
| SCHEMBL4390490 | 0.89 | ALDH1A1 (1.00) | ALDH1A1TSHRTHRBTDP1KEAP1 | |
| SCHEMBL10636466 | 0.89 | — | — | |
| SCHEMBL1849 | 0.89 | — | — | |
| SCHEMBL17558042 | 0.87 | ALDH1A1 (0.75) | ALDH1A1TSHRTHRBTDP1KEAP1 | |
| Methyl Alcohol SCHEMBL1272141 | 0.86 | — | — | |
| Ethylene SCHEMBL44117 | 0.86 | — | — | |
| SCHEMBL21340366 | 0.86 | — | — | |
| SCHEMBL20681605 | 0.86 | — | — | |
| SCHEMBL8627821 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110536916-A | Adhesive composition | Henkel IP & Holding GmbH | 2019-12-03 | — | — | CN | claimed |
| CN-207899027-U | One kind purifying adsorption reaction device for triazole pyrimidone | 马鞍山德鸿生物技术有限公司 | 2018-09-25 | — | — | CN | disclosed |
| US-20030087913-A1 | Solid pharmaceutical agent formulation for a piperazine urea derivative | SCHERING AG (DE) | 2003-05-08 | — | — | US | disclosed |
| CN-1023195-C | Microsuspension process for preparing solvent core sequential polymer dispersion | ROHM & HAAS (US) | 1993-12-22 | — | — | CN | disclosed |
| CN-1041116-A | Method for producing fine capsule dispersion | ROHM & HAAS (US) | 1990-04-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030087913-A1 | Solid pharmaceutical agent formulation for a piperazine urea derivative | SLC14A1, UTS2R, SP1 | ALDH1A1 1795/4885TSHR 2536/4885THRB 4475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.